BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

551 related articles for article (PubMed ID: 17562858)

  • 1. Coordinated regulation of Toll-like receptor and NOD2 signaling by K63-linked polyubiquitin chains.
    Abbott DW; Yang Y; Hutti JE; Madhavarapu S; Kelliher MA; Cantley LC
    Mol Cell Biol; 2007 Sep; 27(17):6012-25. PubMed ID: 17562858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NOD2 pathway activation by MDP or Mycobacterium tuberculosis infection involves the stable polyubiquitination of Rip2.
    Yang Y; Yin C; Pandey A; Abbott D; Sassetti C; Kelliher MA
    J Biol Chem; 2007 Dec; 282(50):36223-9. PubMed ID: 17947236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A critical role of RICK/RIP2 polyubiquitination in Nod-induced NF-kappaB activation.
    Hasegawa M; Fujimoto Y; Lucas PC; Nakano H; Fukase K; Núñez G; Inohara N
    EMBO J; 2008 Jan; 27(2):373-83. PubMed ID: 18079694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Crohn's disease protein, NOD2, requires RIP2 in order to induce ubiquitinylation of a novel site on NEMO.
    Abbott DW; Wilkins A; Asara JM; Cantley LC
    Curr Biol; 2004 Dec; 14(24):2217-27. PubMed ID: 15620648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ITCH K63-ubiquitinates the NOD2 binding protein, RIP2, to influence inflammatory signaling pathways.
    Tao M; Scacheri PC; Marinis JM; Harhaj EW; Matesic LE; Abbott DW
    Curr Biol; 2009 Aug; 19(15):1255-63. PubMed ID: 19592251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The K48-K63 Branched Ubiquitin Chain Regulates NF-κB Signaling.
    Ohtake F; Saeki Y; Ishido S; Kanno J; Tanaka K
    Mol Cell; 2016 Oct; 64(2):251-266. PubMed ID: 27746020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of the canonical IKK complex by K63/M1-linked hybrid ubiquitin chains.
    Emmerich CH; Ordureau A; Strickson S; Arthur JS; Pedrioli PG; Komander D; Cohen P
    Proc Natl Acad Sci U S A; 2013 Sep; 110(38):15247-52. PubMed ID: 23986494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TAB2 and TAB3 activate the NF-kappaB pathway through binding to polyubiquitin chains.
    Kanayama A; Seth RB; Sun L; Ea CK; Hong M; Shaito A; Chiu YH; Deng L; Chen ZJ
    Mol Cell; 2004 Aug; 15(4):535-48. PubMed ID: 15327770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NOD2 downregulates colonic inflammation by IRF4-mediated inhibition of K63-linked polyubiquitination of RICK and TRAF6.
    Watanabe T; Asano N; Meng G; Yamashita K; Arai Y; Sakurai T; Kudo M; Fuss IJ; Kitani A; Shimosegawa T; Chiba T; Strober W
    Mucosal Immunol; 2014 Nov; 7(6):1312-25. PubMed ID: 24670424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The coiled-coil domain of TRAF6 is essential for its auto-ubiquitination.
    Yang K; Zhu J; Sun S; Tang Y; Zhang B; Diao L; Wang C
    Biochem Biophys Res Commun; 2004 Nov; 324(1):432-9. PubMed ID: 15465037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lys63-linked polyubiquitination of IRAK-1 is required for interleukin-1 receptor- and toll-like receptor-mediated NF-kappaB activation.
    Conze DB; Wu CJ; Thomas JA; Landstrom A; Ashwell JD
    Mol Cell Biol; 2008 May; 28(10):3538-47. PubMed ID: 18347055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The c-Jun N-terminal kinase (JNK)-binding protein (JNKBP1) acts as a negative regulator of NOD2 protein signaling by inhibiting its oligomerization process.
    Lecat A; Di Valentin E; Somja J; Jourdan S; Fillet M; Kufer TA; Habraken Y; Sadzot C; Louis E; Delvenne P; Piette J; Legrand-Poels S
    J Biol Chem; 2012 Aug; 287(35):29213-26. PubMed ID: 22700971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oligomerization-primed coiled-coil domain interaction with Ubc13 confers processivity to TRAF6 ubiquitin ligase activity.
    Hu L; Xu J; Xie X; Zhou Y; Tao P; Li H; Han X; Wang C; Liu J; Xu P; Neculai D; Xia Z
    Nat Commun; 2017 Oct; 8(1):814. PubMed ID: 28993672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ac2PIM-responsive miR-150 and miR-143 target receptor-interacting protein kinase 2 and transforming growth factor beta-activated kinase 1 to suppress NOD2-induced immunomodulators.
    Prakhar P; Holla S; Ghorpade DS; Gilleron M; Puzo G; Udupa V; Balaji KN
    J Biol Chem; 2015 Oct; 290(44):26576-86. PubMed ID: 26391398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles of the TRAF6 and Pellino E3 ligases in MyD88 and RANKL signaling.
    Strickson S; Emmerich CH; Goh ETH; Zhang J; Kelsall IR; Macartney T; Hastie CJ; Knebel A; Peggie M; Marchesi F; Arthur JSC; Cohen P
    Proc Natl Acad Sci U S A; 2017 Apr; 114(17):E3481-E3489. PubMed ID: 28404732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IRAK-1-mediated negative regulation of Toll-like receptor signaling through proteasome-dependent downregulation of TRAF6.
    Muroi M; Tanamoto K
    Biochim Biophys Acta; 2012 Feb; 1823(2):255-63. PubMed ID: 22033459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of TRAF6 and pro-inflammatory cytokines through activation of TLR2, TLR4, NOD1, and NOD2 in human periodontal ligament fibroblasts.
    Tang L; Zhou XD; Wang Q; Zhang L; Wang Y; Li XY; Huang DM
    Arch Oral Biol; 2011 Oct; 56(10):1064-72. PubMed ID: 21457942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pro-angiogenic activity of TLRs and NLRs: a novel link between gut microbiota and intestinal angiogenesis.
    Schirbel A; Kessler S; Rieder F; West G; Rebert N; Asosingh K; McDonald C; Fiocchi C
    Gastroenterology; 2013 Mar; 144(3):613-623.e9. PubMed ID: 23149220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. E3 Ubiquitin ligase ZNRF4 negatively regulates NOD2 signalling and induces tolerance to MDP.
    Bist P; Cheong WS; Ng A; Dikshit N; Kim BH; Pulloor NK; Khameneh HJ; Hedl M; Shenoy AR; Balamuralidhar V; Malik NBA; Hong M; Neutzner A; Chin KC; Kobayashi KS; Bertoletti A; Mortellaro A; Abraham C; MacMicking JD; Xavier RJ; Sukumaran B
    Nat Commun; 2017 Jun; 8():15865. PubMed ID: 28656966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of NOD2-mediated intestinal pathway in a pediatric population with Crohn's disease.
    Negroni A; Stronati L; Pierdomenico M; Tirindelli D; Di Nardo G; Mancini V; Maiella G; Cucchiara S
    Inflamm Bowel Dis; 2009 Aug; 15(8):1145-54. PubMed ID: 19266573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.